Implementing Genome-Driven Oncology
Open Access
- 1 February 2017
- journal article
- review article
- Published by Elsevier BV in Cell
- Vol. 168 (4), 584-599
- https://doi.org/10.1016/j.cell.2016.12.015
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersNature, 2012
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerNature, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast CancerNew England Journal of Medicine, 2012
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)Nature, 2011
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaNature, 2010
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Mutations of the BRAF gene in human cancerNature, 2002